WILMINGTON, Del., June 17, 2015 /PRNewswire/ -- Rigrodsky &
Long, P.A.:
- Do you own shares of KYTHERA Biopharmaceuticals, Inc.
(NASDAQ GS: KYTH)?
- Did you purchase any of your shares prior to June 17, 2015?
- Do you think the proposed buyout value is too low?
- Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of KYTHERA
Biopharmaceuticals, Inc. ("KYTHERA" or the "Company") (NASDAQ GS:
KYTH) regarding possible breaches of fiduciary duties and other
violations of law related to the Company's entry into an agreement
to be acquired by Allergan plc ("Allergan") (NYSE: AGN), in a
transaction valued at approximately $2.1
billion.
Click here to learn more:
http://rigrodskylong.com/investigations/kythera-biopharmaceuticals-inc-kyth.
Under the terms of the agreement, shareholders of KYTHERA will
receive $75.00 in cash and Allergan
shares for each share of KYTHERA they own.
The investigation concerns whether KYTHERA's board of directors
failed to adequately shop the Company and obtain the best possible
value for KYTHERA's shareholders before entering into an agreement
with Allergan. According to Yahoo! Finance, at least one analyst
has issued a price target for KYTHERA stock at $85.00 per share.
If you own the common stock of KYTHERA and purchased your shares
before June 17, 2015, if you have
information or would like to learn more about these claims, or if
you wish to discuss these matters or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Seth D.
Rigrodsky or Gina M. Serra at
Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120,
Wilmington, DE 19803, by telephone
at (888) 969-4242; by e-mail to info@rl-legal.com, or at:
http://rigrodskylong.com/investigations/kythera-biopharmaceuticals-inc-kyth.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes
securities class, derivative and direct actions, shareholder rights
litigation and corporate governance litigation, on behalf of
shareholders in states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a
similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kythera-biopharmaceuticals-inc-shareholder-alert-rigrodsky--long-pa-announces-investigation-of-buyout-300100776.html
SOURCE Rigrodsky & Long, P.A.